We are pleased to accept San Antonio-based biotech startup, Generic Genomics into the Bioscience Incubator. Founded by Dr. David Feldman, Generic Genomics is working to develop new cell-based, immunotherapies for cancer applications. Generic Genomics joins our cohort of companies at ACC Highland.
Recent Posts
Archives
- May 2024 (1)
- September 2023 (5)
- December 2022 (1)
- October 2022 (1)
- September 2022 (4)
- November 2021 (2)
- October 2021 (1)
- September 2021 (1)
- August 2021 (1)
- July 2021 (1)
- May 2021 (1)
- April 2021 (1)
- March 2021 (3)
- November 2020 (1)
- August 2020 (2)
- July 2020 (3)
- June 2020 (2)
- March 2020 (2)
- February 2020 (1)
- January 2020 (1)
- November 2019 (1)
- October 2019 (1)
- September 2019 (4)
- July 2019 (1)
- June 2019 (3)
- May 2019 (1)
- April 2019 (1)
- March 2019 (1)
- February 2019 (3)
- January 2019 (1)
- October 2018 (2)
- August 2018 (1)
- June 2018 (1)
- May 2018 (5)
- April 2018 (2)
- March 2018 (2)
- February 2018 (1)
- January 2018 (2)
- December 2017 (3)
- October 2017 (5)
- September 2017 (1)
- August 2017 (3)
- July 2017 (2)
- June 2017 (2)
- May 2017 (3)
- April 2017 (5)
- March 2017 (1)
- February 2017 (3)
- January 2017 (3)
- December 2016 (1)
- November 2016 (2)
- September 2016 (2)
- July 2016 (1)
- February 2016 (1)
- January 2016 (1)
- February 2015 (1)
Tags
A2LA
ACC Bioscience Incubator
accreditation
ATI
austin
Bioscience Incuabtor
biotech
biotechnology
Capital City Innovation
Celling Biosciences
chemistry
Entrepreneurship
EQO
events
Fabrico
Food and Ag Lab
Food safety
Funding
Grants
imaging
immunotherapy
interns
internship
life sciences
Lunch and Learn
Lung Therapeutics
member companies
NACCE
networking
News
pharmaceuticals
podcast
Poster Session
Press
Research
SBIR
series C
STEM
stem cells
Students
Therapeutics
The University of Texas
workforce development
Workshop
zebra mussels